James A. Swenberg
About
In The Last Decade
James A. Swenberg
350 papers receiving 19.7k citations
Hit Papers
Peers
Comparison fields: 5 of 181
- Molecular Biology 10.9k
- Cancer Research 6.7k
- Health, Toxicology and Mutagenesis 5.0k
- Oncology 1.7k
- Plant Science 1.3k
Countries citing papers authored by James A. Swenberg
This map shows the geographic impact of James A. Swenberg's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by James A. Swenberg with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites James A. Swenberg more than expected).
Fields of papers citing papers by James A. Swenberg
This network shows the impact of papers produced by James A. Swenberg. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by James A. Swenberg. The network helps show where James A. Swenberg may publish in the future.
Co-authorship network of co-authors of James A. Swenberg
This figure shows the co-authorship network connecting the top 25 collaborators of James A. Swenberg. A scholar is included among the top collaborators of James A. Swenberg based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with James A. Swenberg. James A. Swenberg is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 74 | |
| 2 | 6 | |
| 3 | 359 | |
| 4 | Tet Proteins Can Convert 5-Methylcytosine to 5-Formylcytosine and 5-Carboxylcytosine breakdown → | 2619 |
| 5 | 59 | |
| 6 | 71 | |
| 7 | 27 | |
| 8 | 49 | |
| 9 | 1,3-butadiene: cancer, mutations, and adducts. Part V: Hemoglobin adducts as biomarkers of 1,3-butadiene exposure and metabolism | 2 |
| 10 | 68 | |
| 11 | 12 | |
| 12 | 108 | |
| 13 | The presence of alpha 2u-globulin is necessary for d-limonene promotion of male rat kidney tumors. | 126 |
| 14 | Promoting effects of unleaded gasoline and 2,2,4-trimethylpentane on the development of atypical cell foci and renal tubular cell tumors in rats exposed to N-ethyl-N-hydroxyethylnitrosamine. | 45 |
| 15 | Molecular dosimetry of O4-ethyldeoxythymidine in rats continuously exposed to diethylnitrosamine. | 42 |
| 16 | Accumulation and persistence of DNA adducts in respiratory tissue of rats following multiple administrations of the tobacco specific carcinogen 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone. | 86 |
| 17 | 1,2-Dimethylhydrazine-induced methylation of DNA bases in various rat organs and the effect of pretreatment with disulfiram. | 74 |
| 18 | Neoplasms in purebred boxer dogs following long-term administration of N-methyl-N-nitrosourea. | 9 |
| 19 | Detection of DNA damage induced in vivo following exposure of rats to carcinogens. | 117 |
| 20 | 4 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.